BioSyntech announces CEO as they work on strategic initiatives with PricewaterhouseCoopers, stock price reaches $0.12 |

BioSyntech announces CEO as they work on strategic initiatives with PricewaterhouseCoopers, stock price reaches $0.12

  http://ow.ly/kdDD

Other Sports Medicine startups…  https://orthostreams.com/?page_id=904

Leave a Reply

Your email address will not be published. Required fields are marked *